MusclePharm | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-White Winston Select Asset Fund Series Fund MP-18, LLC(8.80%),White Winston Select Asset Funds, LLC(8.80%), etc.
Dec 21, 2022 17:22 ET
MusclePharm | 4: Statement of changes in beneficial ownership of securities
Jul 28, 2022 16:17 ET
MusclePharm | 3: Initial statement of beneficial ownership of securities-Officer Rizvi Sabina
Jul 28, 2022 16:15 ET
MusclePharm | 3: Initial statement of beneficial ownership of securities-Chief Accounting Officer Chin Eric
Jun 22, 2022 16:15 ET
MusclePharm | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-White Winston Select Asset Fund Series Fund MP-18, LLC(9.05%),White Winston Select Asset Funds, LLC(9.05%), etc.
Apr 1, 2022 16:38 ET
MusclePharm | 4: Statement of changes in beneficial ownership of securities
Mar 31, 2022 19:19 ET
MusclePharm | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-White Winston Select Asset Fund Series Fund MP-18, LLC(10.93%),White Winston Select Asset Funds, LLC(10.93%), etc.
Feb 22, 2022 11:22 ET
MusclePharm | 4: Statement of changes in beneficial ownership of securities
Aug 17, 2021 21:56 ET
MusclePharm | 3: Initial statement of beneficial ownership of securities
Jun 11, 2021 17:06 ET
MusclePharm | 3: Initial statement of beneficial ownership of securities
Jan 29, 2021 12:03 ET
MusclePharm | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Dec 2, 2020 16:58 ET
MusclePharm | 4: Statement of changes in beneficial ownership of securities
Dec 1, 2020 17:00 ET
MusclePharm | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Nov 3, 2020 16:23 ET
MusclePharm | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Oct 28, 2020 15:57 ET
MusclePharm | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Jul 13, 2020 14:07 ET
MusclePharm | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Nov 8, 2019 14:04 ET
MusclePharm | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)
Nov 8, 2019 12:26 ET
MusclePharm | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)
Nov 8, 2019 12:18 ET
MusclePharm | SC 13D/A: Schedule filed to report acquisition of beneficial ownership of more than 5% of a class of equity securities (Amendment)
Oct 7, 2019 16:48 ET
MusclePharm | 4: Statement of changes in beneficial ownership of securities
Oct 2, 2019 21:36 ET
No Data
No Data